Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.52 – $13.65
0% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7M | $2.2M | $480.0K | $2.0M | $122.0K | $183.0K |
| Cost of revenue | $1.7M | $1.5M | $8.6M | $9.8M | $0 | $0 |
| Gross profit | −$28.0K | $676.0K | −$8.1M | −$7.7M | $122.0K | $183.0K |
| Gross margin | -1.7% | 30.7% | -1697.3% | -380.7% | 100.0% | 100.0% |
| R&D | $1.1M | $6.1M | $8.6M | $9.8M | $4.3M | $3.0M |
| Operating income | $5.4M | −$12.4M | −$15.0M | −$16.7M | −$11.7M | −$9.9M |
| EBITDA | −$6.0M | −$12.2M | −$14.5M | −$15.8M | −$10.9M | −$6.2M |
| Net income | −$5.5M | −$12.4M | −$14.7M | −$17.2M | −$11.7M | −$7.2M |
| Net margin | -327.2% | -561.4% | -3069.8% | -848.4% | -9595.1% | -3951.9% |
| EPS (diluted) | -14.10 | -31.50 | -47.70 | -55.50 | -37.50 | -23.10 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $237840 | $-6.90 | $-6.90–$-6.90 | 1 |
| 2027 | $271145 | $-10.20 | $-10.20–$-10.20 | 1 |
| 2028 | $309114 | $-12.00 | $-12.00–$-12.00 | 1 |
| 2029 | $352400 | $-15.30 | $-15.30–$-15.30 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ABP.
No tracked institution reports a position in ABP as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-11-03 | 1-for-30reverse |
No one on the platform has traded ABP yet.
| $30M |
| — |
| CLRBCellectar Biosciences, Inc. | $2.60 | +3.17% | $8M | — |
| EVGNEvogene Ltd. | $0.43 | +10.93% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
@Rolo2024 yes it is possible... i made a lot DD here. Relisting coming $ABP
View on StockTwits ↗$ABP Up 117% in the last month?! Whats going on? Getting relisted in stock exchange?
View on StockTwits ↗@f1rew1re very interesting news ! $ABP as is earlier said . maybe COMEBACk of the year
View on StockTwits ↗$ABP rumors of RELISTING for $ABP . wi will HOLD
View on StockTwits ↗@CMDC1023 yes ! i hope so -> $ABP .... i saw it in other stocks ! would be really crazy
View on StockTwits ↗$ABP another scam bites the dust. Can’t file on time cuz they have no money.
View on StockTwits ↗$ABP Abpro Bio Co., Ltd. resumed trading on the KOSDAQ today following a reverse split.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.